GB1138421A - Preparation of optically active isomers of serine - Google Patents

Preparation of optically active isomers of serine

Info

Publication number
GB1138421A
GB1138421A GB383867A GB383867A GB1138421A GB 1138421 A GB1138421 A GB 1138421A GB 383867 A GB383867 A GB 383867A GB 383867 A GB383867 A GB 383867A GB 1138421 A GB1138421 A GB 1138421A
Authority
GB
United Kingdom
Prior art keywords
enantiomorph
serine
solution
paratoluenesulphonate
crystals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB383867A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of GB1138421A publication Critical patent/GB1138421A/en
Expired legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1,138,421. Resolving DL-serine paratoluenesulphonate. TANABE SEIYAKU CO. Ltd. 25 Jan., 1967 [25 Jan., 1966], No. 3838/67. Heading C2C. DL-Serine paratoluenesulphonate is resolved by preparing a supersaturated solution of DL- serine paratoluenesulphonate in an inert solvent therefor, adding crystals of the desired enantiomorph to the solution before and/or after the said solution reaches supersaturation so that the proportion of one enantiomorph becomes greater than that of the other, allowing crystallization to take place and recovering the separated crystals. In one embodiment a small quantity of crystals of the desired enantiomorph is used to inoculate the supersaturated solution and the mixture is stirred to induce crystallization. In another embodiment, a small quantity of one enantiomorph is dissolved in a hot solution of the racemic modification. A combination of these embodiments may also be used. Specified solvents are water, alkanols and ketones having up to 6 carbon atoms and mixtures thereof. After the first crop of enantiomorph is filtered off, the mother liquor may be used for separating the other enantiomorph. Free serine can be liberated by conventional methods.
GB383867A 1966-01-25 1967-01-25 Preparation of optically active isomers of serine Expired GB1138421A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP450666 1966-01-25

Publications (1)

Publication Number Publication Date
GB1138421A true GB1138421A (en) 1969-01-01

Family

ID=11585924

Family Applications (1)

Application Number Title Priority Date Filing Date
GB383867A Expired GB1138421A (en) 1966-01-25 1967-01-25 Preparation of optically active isomers of serine

Country Status (6)

Country Link
BE (1) BE693041A (en)
CH (1) CH475172A (en)
DE (1) DE1543934A1 (en)
FR (1) FR1508859A (en)
GB (1) GB1138421A (en)
NL (2) NL6701085A (en)

Also Published As

Publication number Publication date
BE693041A (en) 1967-07-03
CH475172A (en) 1969-07-15
NL6701085A (en) 1967-07-26
DE1543934A1 (en) 1972-02-24
NL130967C (en)
FR1508859A (en) 1968-03-20

Similar Documents

Publication Publication Date Title
ES354952A1 (en) Alpha-glycolide and methods for the isolation thereof
ES400862A1 (en) Optical isomers of binaphthyl-phosphoric acids
Freudenberg et al. STUDY ON THE CONFIGURATION OF EPHEDRINE1
Manske et al. The Alkaloids of Fumariaceous Plants. XXXIX. The Constitution of Capaurine
US4727147A (en) Optically active 1-(4-methoxybenzyl)-1,2,3,4,5,6,7,8-octahydroisoquinolinium acetates
GB1138421A (en) Preparation of optically active isomers of serine
US2790001A (en) Resolution of amino acids
GB1177856A (en) Process for Resolution of Optical Isomers or Racemic Ammonium Pantoate by Preferential Crystallization
GB1182008A (en) Resolution of d1-(3-Trifluoromethylphenoxy)-(4-Chlorophenyl)Acetic Acid
US2882302A (en) Purification of glutamic acid enantiomorphs
GB1455710A (en) Resolution of optically active compounds
US3742041A (en) Process of resolving dl-serine m-xylene-4-sulfonate
ES372055A1 (en) Process for the preparation of a salt of optically active lysine
FR2114772A5 (en)
GB1505048A (en) Ether carboxylate monohydrate and its preparation
ES433589A1 (en) Method for crystallization of fructose from water solution
GB1413032A (en) Aqueous crystallization of sylitol
US3607929A (en) Increasing the optical purity of l-lysine monohydrochloride
US3361810A (en) Process for treating glutamic acid salts
SU421355A1 (en) METHOD OF CULTIVATION OF KALIA BIFTALATE MONOCRYSTALS
SU132627A1 (en) Purification method rubidi chloride
FR2091396A5 (en) Dopa optical resolution by selective crystallization from superstaura
GB1256416A (en) RECOVERY OF alpha-AMINO-epsilon-CAPROLACTAM MONOHYDROCHLORIDE OF ENHANCED OPTICAL PURITY
ES426007A1 (en) A procedure for the optimum resolution of racemic lysine sulphanylate. (Machine-translation by Google Translate, not legally binding)
GB1346658A (en) Resolution of 2- -2beta-benzyloxy-methyl-3-alpha-hydroxy-4-cyclo penten-1alpha-yl- acetic acid